353 related articles for article (PubMed ID: 15658869)
1. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
2. A new family of quinoline and quinoxaline analogues of combretastatins.
Pérez-Melero C; Maya AB; del Rey B; Peláez R; Caballero E; Medarde M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3771-4. PubMed ID: 15203159
[TBL] [Abstract][Full Text] [Related]
3. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303
[TBL] [Abstract][Full Text] [Related]
6. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
7. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
8. 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines as a new class of potent antitubulin agents.
Lo YH; Lin CC; Lin CF; Lin YT; Duh TH; Hong YR; Yang SH; Lin SR; Yang SC; Chang LS; Wu MJ
J Med Chem; 2008 May; 51(9):2682-8. PubMed ID: 18386884
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4.
Maya AB; del Rey B; Lamamie de Clairac RP; Caballero E; Barasoain I; Andreu JM; Medarde M
Bioorg Med Chem Lett; 2000 Nov; 10(22):2549-51. PubMed ID: 11086727
[TBL] [Abstract][Full Text] [Related]
12. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.
Ohsumi K; Nakagawa R; Fukuda Y; Hatanaka T; Morinaga Y; Nihei Y; Ohishi K; Suga Y; Akiyama Y; Tsuji T
J Med Chem; 1998 Jul; 41(16):3022-32. PubMed ID: 9685242
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
Liou JP; Chang JY; Chang CW; Chang CY; Mahindroo N; Kuo FM; Hsieh HP
J Med Chem; 2004 May; 47(11):2897-905. PubMed ID: 15139768
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
15. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
16. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
17. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
18. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
Kaffy J; Pontikis R; Florent JC; Monneret C
Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
[TBL] [Abstract][Full Text] [Related]
20. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C
J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
